Skip to main content
. 2016 Jul 1;18(11):1529–1537. doi: 10.1093/neuonc/now133

Fig. 2.

Fig. 2.

Principal efficacy outcomes per treatment. Data of progression-free survival (PFS; (panel A), time-to-treatment failure (TTF; panel B), and overall survival (OS; panel C) were analyzed by treatment arm.